市場調査レポート
商品コード
1099682
バルビツール酸系薬剤の世界市場規模調査:薬剤タイプ別、疾患タイプ別、流通チャネル別、地域別予測(2022年~2028年)Global Barbiturate Drugs Market Size study, by Drug Type, by Disease Type, by Distribution Channel, and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
バルビツール酸系薬剤の世界市場規模調査:薬剤タイプ別、疾患タイプ別、流通チャネル別、地域別予測(2022年~2028年) |
出版日: 2022年06月21日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
高齢者人口の増加、不眠症の有病率の上昇、社会におけるストレスレベルの上昇は市場の成長を牽引しています。
しかし、バルビツール酸系薬剤に伴う副作用が市場成長を抑制していると考えられます。
当レポートでは、世界のバルビツール酸系薬剤市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。
List of figures
Global Barbiturate Drugs Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Barbiturates are drugs that affect the central nervous system. Barbiturates are chemical derivatives of barbituric acid. Barbiturate medicines come in a variety of forms, but they all have a relaxing impact on the central nervous system and are used to treat anxiety in therapeutic settings. Sleeplessness, Epilepsy, and status epilepticus are all treated with barbiturates. Barbiturate medications come in tablet form and can be administered either orally or intravenously. Increase in geriatric population and rise in prevalence of target diseases drive the growth of Barbiturate drug market. For instance, as per Statista, Japan had the largest proportion of the total population over the age of 65 in 2021. Japan boasts the world's oldest population, with 29 percent of the population over 65. Germany, on the other hand, will have 22% of its population over the age of 65 in 2021. Furthermore, according to Gallup, employees in the United States and Canada saw the greatest levels of daily stress (57 percent), whereas stress in Western Europe fell to 39 percent in 2019 from 46 percent in 2018. Also, with the rise in prevalence of insomnia and rising stress levels in society the adoption & demand for Barbiturate Drugs is likely to increase the market growth during the forecast period However, side effects associated with Barbiturate Drugs impede the growth of the market over the forecast period of2022-2028.
The key regions considered for the global Barbiturate Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market share globally, owing to the highest percentage of insomnia affected patients. However, Barbiturate medications are predicted to be the second most popular in Asia Pacific, excluding Japan. The growing stress level of the working population, as well as the quickly developing healthcare infrastructure, may be contributed to the market's growth in the region.
Major market players included in this report are:
Par Pharmaceutical
Intas Pharmaceuticals Ltd.
Samarth Life Sciences Pvt. Ltd.
Centurion Healthcare Private Limited
Ethypharm
Abbott
Akorn Operating Company LLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
By Disease Type:
Epilepsy
Insomnia
Sedation
Other Disease Type
By Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Other Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Barbiturate Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors